DaVita price target raised to $136 from $114 at Deutsche Bank Deutsche Bank raised its price target for DaVita to reflect its 2014 estimates and calls the company its top pick within Health Care Providers. The firm reiterates a Buy rating on the name.
News For DVA From The Last 14 Days
Check below for free stories on DVA the last two weeks.